| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.62B | 1.67B | 1.65B | 1.69B | 1.44B | 736.90M |
| Gross Profit | 78.06M | 383.40M | 381.10M | 400.80M | 329.20M | 174.80M |
| EBITDA | 107.10M | 73.80M | -59.40M | 104.30M | 74.60M | -66.00M |
| Net Income | 20.50M | 13.60M | -113.50M | 40.30M | 37.10M | -104.50M |
Balance Sheet | ||||||
| Total Assets | 1.35B | 1.35B | 1.37B | 1.42B | 1.47B | 1.34B |
| Cash, Cash Equivalents and Short-Term Investments | 131.69M | 144.00M | 160.10M | 115.30M | 64.70M | 107.70M |
| Total Debt | 365.96M | 357.00M | 328.80M | 268.00M | 336.00M | 549.60M |
| Total Liabilities | 812.48M | 787.20M | 780.60M | 683.70M | 769.70M | 889.50M |
| Stockholders Equity | 537.09M | 560.70M | 587.00M | 739.20M | 699.00M | 446.10M |
Cash Flow | ||||||
| Free Cash Flow | 66.27M | 42.40M | 63.30M | 70.80M | 15.90M | -104.60M |
| Operating Cash Flow | 78.10M | 60.90M | 83.30M | 86.00M | 33.00M | -94.60M |
| Investing Cash Flow | -11.23M | -15.10M | -19.50M | 49.10M | -2.20M | -9.20M |
| Financing Cash Flow | -75.80M | -66.90M | -20.90M | -83.20M | -76.30M | 86.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £15.42B | 17.33 | 28.56% | 1.96% | 6.00% | 42.42% | |
70 Outperform | £688.62M | 7.17 | 15.23% | 2.74% | 3.97% | 34.09% | |
66 Neutral | £31.18B | 5.98 | 19.40% | 5.00% | -2.83% | -40.42% | |
65 Neutral | £405.90M | 9.36 | 3.72% | 4.05% | -2.22% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £896.49M | 16.71 | 9.32% | 2.11% | -6.03% | 13.11% | |
54 Neutral | £50.21M | -4.50 | -2.23% | ― | -15.87% | 90.20% |